Infectious Disease

Identify Tissue-of-Origin in Circulating Cell Free DNA by Inferred Epigenomic Pattern from Whole Genome Sequencing

Header and Body 1

Header and Body 2

Header and Body 3

Header and Body 4

Read more about Identify Tissue-of-Origin in Circulating Cell Free DNA by Inferred Epigenomic Pattern from Whole Genome Sequencing

Diazene Directed Modular Synthesis of Oligocyclotryptamines

Read more about Diazene Directed Modular Synthesis of Oligocyclotryptamines

Engineered Phagemids for Non-Lytic, Targeted Antibacterial Technologies

Read more about Engineered Phagemids for Non-Lytic, Targeted Antibacterial Technologies

Fine-tuning pKa's of Nucleoside Analogs to Increase Mutagenicity; a Strategy to Develop More Potent Lethal Mutagen with Anti-Viral or Anticancer Properties

Read more about Fine-tuning pKa's of Nucleoside Analogs to Increase Mutagenicity; a Strategy to Develop More Potent Lethal Mutagen with Anti-Viral or Anticancer Properties

Antimicrobial Peptides Against Bacterial Pathogens

Read more about Antimicrobial Peptides Against Bacterial Pathogens

Computational Platform for in Silico Combinatorial Sequence Space Exploration and Artificial Evolution of Peptides

Read more about Computational Platform for in Silico Combinatorial Sequence Space Exploration and Artificial Evolution of Peptides

Mucins as Regulators of Interspecies Microbial Interactions

Read more about Mucins as Regulators of Interspecies Microbial Interactions

Method for Assessing Cytotoxicity of Single Cells

Read more about Method for Assessing Cytotoxicity of Single Cells

Massachusetts Institute of Technology

MIT Technology Licensing Office

Technology
Licensing
Office

Pre-Fever Detection of Infection

Specific Rapid Antigen Diagnostic Tests Based on Cross-Reactive Monoclonal Antibodies

Identify Tissue-of-Origin in Circulating Cell Free DNA by Inferred Epigenomic Pattern from Whole Genome Sequencing

Diazene Directed Modular Synthesis of Oligocyclotryptamines

Engineered Phagemids for Non-Lytic, Targeted Antibacterial Technologies

Fine-tuning pKa's of Nucleoside Analogs to Increase Mutagenicity; a Strategy to Develop More Potent Lethal Mutagen with Anti-Viral or Anticancer Properties

Antimicrobial Peptides Against Bacterial Pathogens

Computational Platform for in Silico Combinatorial Sequence Space Exploration and Artificial Evolution of Peptides

Mucins as Regulators of Interspecies Microbial Interactions

Method for Assessing Cytotoxicity of Single Cells